Advisory for COVID-19 testing during the second wave of the pandemic, issued by the ICMR.
Dear all,
Your association SIMA is forwarding herewith an advisory for COVID-19 testing during the second wave of the pandemic issued by the Indian Council of Medical Research, dated 04/05/2021.
As you all aware that, an unprecedented upsurge of COVID-19 cases and deaths is currently being witnessed across India. The overall nationwide test positivity rate is above 20%. Testing-tracking-tracing, isolation and home-based treatment of positive patients is the key measure to curb transmission of SARS-CoV-2, the causative agent of COVID-19. India has a total of 2506 molecular testing laboratories including RTPCR, TrueNat, CBNAAT and other platforms. The total daily National testing capacity is close to 15 lakh tests considering a three-shift operationalization of the existing laboratory network. At present, the laboratories are facing challenges to meet the expected testing target due to extraordinary caseload and staff getting infected with COVID-19. In view of this situation, it is imperative to optimize the RTPCR testing and simultaneously increase the access and availability of testing to all citizens of the country.
TO VIEW THE FULL ADVISORY, PLEASE CLICK HERE.
ThankingYou,
With regards,
For Silvassa Industries & Manufacturers Association
Narendra Trivedi
Secretary
